李振彰博士团队的研究方法使用了深度学习算法，通过训练模型，使其能够从海量内窥镜图像中学习并识别出可能的癌症病变。这一过程不仅提升了早期诊断的准确性，也大大降低了对专业医疗设备的依赖，为基层医疗提供了更加便捷和可及的解决方案。

ALEC-04 is under clinical development by Alentis Therapeutics and currently in Phase II for Nasopharyngeal Cancer.

Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after ...

Tevimbra is under clinical development by BeiGene and currently in Phase III for Nasopharyngeal Cancer. According to GlobalData, Phase III drugs for Nasopharyngeal Cancer have a 67% phase transition ...

Chin was diagnosed with nasopharyngeal cancer in November 2022 when doctors discovered he had a tumor in his nasal cavity. By January 2023, he started his three months of radiation and chemotherapy.

Chin was diagnosed with nasopharyngeal cancer in November 2022. He started three months of radiation and chemotherapy in January 2023 and was diagnosed cancer-free that fall. “It really takes a ...

Doctors at AIIMS, Delhi are in the process of developing a low cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer. This kind of therapy is expected ...

1GuangDong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

But knowing your risk can help you watch for signs of cancer, especially if you have more than one risk factor. Watching for signs of nasopharyngeal cancer if you have had mono New research has shown ...

1 Department of Radiology, Affiliated Hospital of Qingdao University, Qingdao, China 2 The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China Background: The expression level of Ki-67 ...